Michael Berger
20Patents
6h-index
25Co-inventors
69Inventor score
Filing activity: Sep 21, 1981 → May 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4590556A | Co-processor combination | Physics | 67 | Expired |
| US4679166A | Co-processor combination | Physics | 65 | Expired |
| US4545016A | Memory management system | Physics | 40 | Expired |
| US4625301A | Dynamic memory refresh circuit | Physics | 23 | Expired |
| US4649514A | Computer revision port | Physics | 21 | Expired |
| US4443883A | Data synchronization apparatus | Physics | 10 | Expired |
| US4468753A | Input/output buffer circuitry | Physics | 4 | Expired |
| US8883791B2 | N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases | Chemistry; Metallurgy | 3 | Active |
| US11406617B2 | Compounds for the treatment of bovine or swine respiratory disease | Human Necessities | 1 | Active |
| US11034650B2 | Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection | Emerging Cross-Sectional Technologies | 1 | Active |
| US11441190B2 | Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function | Chemistry; Metallurgy | 0 | Active |
| US10562834B2 | Process for preparing substituted crotonic acids | Chemistry; Metallurgy | 0 | Active |
| US9321724B2 | Heteroaryl compounds with A-cyclic bridging unit | Chemistry; Metallurgy | 0 | Active |
| US9260441B2 | Heteroaryl compounds with cyclic bridging unit | Chemistry; Metallurgy | 0 | Active |
| US12157717B2 | Compounds for the treatment of bovine or swine respiratory disease | Chemistry; Metallurgy | 0 | Active |
| US12227485B2 | Compounds useful for the treatment of infection with Mannheimia haemolytica or Histophilus somni | Chemistry; Metallurgy | 0 | Active |
| US8877934B2 | N-heteroaryl compounds | Chemistry; Metallurgy | 0 | Active |
| US12077488B2 | Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US8973017B2 | Productivity application management | Physics | 0 | Active |
| US10610521B2 | Biomarkers for response to rapamycin analogs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.